Literature DB >> 9525942

Specific binding of phosphatidylinositol 4,5-bisphosphate to calcium-dependent activator protein for secretion (CAPS), a potential phosphoinositide effector protein for regulated exocytosis.

K M Loyet1, J A Kowalchyk, A Chaudhary, J Chen, G D Prestwich, T F Martin.   

Abstract

The calcium-dependent activator protein for secretion (CAPS) is a novel neural/endocrine-specific cytosolic and peripheral membrane protein required for the Ca2+-regulated exocytosis of secretory vesicles. CAPS acts at a stage in exocytosis that follows ATP-dependent priming, which involves the essential synthesis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). In the present studies, CAPS is shown to bind liposomes that contain acidic phospholipids and binding was markedly enhanced by inclusion of PtdIns(4,5)P2 but not other phosphoinositides in the absence of Ca2+. PtdIns(4,5)P2, but not other phosphoinositides including PtdIns(3, 4)P2 and PtdIns(3,4,5)P3, altered the susceptibility of CAPS to proteolysis by trypsin and proteinase K, suggesting that phosphoinositide binding promoted a conformational change. Photoaffinity labeling studies with a photoactivatable benzoylcinnimidyl acyl chain derivative of PtdIns(4,5)P2 confirmed the phosphoinositide-binding properties of CAPS and suggested a hydrophobic aspect of the interaction. CAPS, as one of very few characterized proteins with a binding specificity for 4-, 5-phosphorylated inositides over 3-phosphorylated inositides, may function in regulated exocytosis as an effector of PtdIns(4,5)P2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525942     DOI: 10.1074/jbc.273.14.8337

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Ca(2+)-dependent activator protein for secretion is critical for the fusion of dense-core vesicles with the membrane in calf adrenal chromaffin cells.

Authors:  A Elhamdani; T F Martin; J A Kowalchyk; C R Artalejo
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

2.  Modulation of HIV-like particle assembly in vitro by inositol phosphates.

Authors:  S Campbell; R J Fisher; E M Towler; S Fox; H J Issaq; T Wolfe; L R Phillips; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

3.  Models of eukaryotic gradient sensing: application to chemotaxis of amoebae and neutrophils.

Authors:  Andre Levchenko; Pablo A Iglesias
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

Review 4.  Formation, stabilisation and fusion of the readily releasable pool of secretory vesicles.

Authors:  Jakob Balslev Sørensen
Journal:  Pflugers Arch       Date:  2004-03-02       Impact factor: 3.657

Review 5.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

Review 6.  The interface between phosphatidylinositol transfer protein function and phosphoinositide signaling in higher eukaryotes.

Authors:  Aby Grabon; Vytas A Bankaitis; Mark I McDermott
Journal:  J Lipid Res       Date:  2018-11-30       Impact factor: 5.922

7.  Plasmalemmal phosphatidylinositol-4,5-bisphosphate level regulates the releasable vesicle pool size in chromaffin cells.

Authors:  Ira Milosevic; Jakob B Sørensen; Thorsten Lang; Michael Krauss; Gábor Nagy; Volker Haucke; Reinhard Jahn; Erwin Neher
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 8.  Analysis of the late steps of exocytosis: biochemical and total internal reflection fluorescence microscopy (TIRFM) studies.

Authors:  Ronald W Holz
Journal:  Cell Mol Neurobiol       Date:  2006-04-20       Impact factor: 5.046

9.  A new approach to the molecular analysis of docking, priming, and regulated membrane fusion.

Authors:  Tatiana P Rogasevskaia; Jens R Coorssen
Journal:  J Chem Biol       Date:  2011-02-08

10.  Ca-dependent nonsecretory vesicle fusion in a secretory cell.

Authors:  Tzu-Ming Wang; Donald W Hilgemann
Journal:  J Gen Physiol       Date:  2008-06-18       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.